Jiangsu Hengrui’s debut on the Hong Kong Stock Exchange generated significant market excitement, with shares skyrocketing after its initial public offering (IPO). Driven by robust investor demand and […]
Hengrui Pharmaceuticals Makes Successful IPO Debut on Hong Kong Stock Exchange
Jiangsu Hengrui Pharmaceuticals, China’s leading pharmaceutical company, successfully launched its IPO in Hong Kong on May 23rd, 2025, raising HK$9.9 billion. This marks a significant development for Hong […]